In addition, Sandra Demaria from the Weill Cornell Medical College in New York, USA, addressed the enhancement of response to immunotherapy by RT based on combining RT with cytotoxic T lymphocyte-associated protein 4 (CTLA-4) blockade in lung cancer. This evidence concerns the gene CTLA4 and lung cancer.